Amir Samuel

Amir Samuel, VMD, ACIM, MBA, has extensive experience in medical affairs, particularly in haematology and oncology. Currently serving as Director of Worldwide Medical Affairs for Haematology at Bristol Myers Squibb, Amir has also held positions such as Acting Country Medical Director and Associate Medical Director for Haematology & Oncology in Australia and New Zealand. Prior roles include Senior Medical Scientist in Global Medical Affairs at Amgen, where responsibilities included leading haematology initiatives, and various roles at Roche, Eli Lilly and Company, and Schering-Plough Research Institute, focusing on medical affairs and product specialization. Amir holds an MBA in Business Administration from Swinburne University of Technology and an Advanced Diploma in Graphic Design from Chisholm Institute.